MedPath

Sintetica SA

Sintetica SA logo
🇨🇭Switzerland
Ownership
Holding
Established
1921-01-01
Employees
-
Market Cap
-
Website
http://www.sintetica.com

Clinical Trials

26

Active:13
Completed:10

Trial Phases

3 Phases

Phase 1:15
Phase 2:4
Phase 3:5

Drug Approvals

7

SFDA:5
FDA:2

Drug Approvals

NA

Approval Date
Oct 1, 2022
FDA

NA

Approval Date
Jul 12, 2022
FDA

Clinical Trials

Distribution across different clinical trial phases (24 trials with phase data)• Click on a phase to view related trials

Phase 1
15 (62.5%)
Phase 3
5 (20.8%)
Phase 2
4 (16.7%)

Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population

Phase 3
Completed
Conditions
Local Anesthetic
Interventions
First Posted Date
2023-07-03
Last Posted Date
2025-03-18
Lead Sponsor
Sintetica SA
Target Recruit Count
74
Registration Number
NCT05926258
Locations
🇮🇹

IRCCS Ospedale San Raffaele, Milano, MI, Italy

🇮🇹

ASST Grande Ospedale Metropolitano Niguarda, Milano, MI, Italy

🇮🇹

Ospedale della Donna e del Bambino, Ospedale Borgo Trento, Azienda Ospedaliera Universitaria Integrata, Verona, VR, Italy

Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Subjects
Interventions
Drug: Ocular gel
First Posted Date
2021-03-03
Last Posted Date
2021-09-16
Lead Sponsor
Sintetica SA
Target Recruit Count
105
Registration Number
NCT04779606
Locations
🇨🇭

CROSS Research S.A., Arzo, Switzerland

Efficacy, Safety and Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

Phase 2
Completed
Conditions
Healthy Volunteers
Interventions
Drug: Ocular gel
First Posted Date
2021-02-15
Last Posted Date
2022-03-17
Lead Sponsor
Sintetica SA
Target Recruit Count
96
Registration Number
NCT04753710
Locations
🇦🇹

Department of Clinical Pharmacology, Vienna, Austria

Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.

Phase 3
Completed
Conditions
Cataract
Interventions
First Posted Date
2020-12-28
Last Posted Date
2023-01-18
Lead Sponsor
Sintetica SA
Target Recruit Count
338
Registration Number
NCT04685538
Locations
🇮🇹

Policlinico S. Orsola-Malpighi - Dipartimento testa collo, U.O. Oftalmologia Ciardella, Bologna, Italy

🇮🇹

A.O. Mater Domini di Catanzaro - U.O. Oculistica, Catanzaro, Italy

🇮🇹

A.O.U. Careggi di Firenze - Dipartimento neuromuscoloscheletrico e organi di senso, reparto di oculistica, Firenze, Italy

and more 24 locations

The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population

Phase 2
Recruiting
Conditions
Hernia, Inguinal
Flat Foot
Interventions
First Posted Date
2019-04-18
Last Posted Date
2024-07-10
Lead Sponsor
Sintetica SA
Target Recruit Count
174
Registration Number
NCT03918798
Locations
🇮🇹

Ospedale Pediatrico Bambin Gesù di Roma Dipartimento di Emergenza Accettazione (DEA) e A.R.C.O, Roma, Lazio, Italy

🇮🇹

Fondazione Policlinico Universitario Agostino Gemelli U.O.C. Anestesia delle Chirurgie Generali del Policlinico, Roma, Lazio, Italy

🇮🇹

Ospedale San Raffaele Anestesia e Rianimazione del distretto testacollo, Milano, Lombardia, Italy

and more 6 locations
  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.